Aerobic interval training enhances cardiomyocyte contractility and Ca2+ cycling by phosphorylation of CaMKII and Thr-17 of phospholamban.
Cardiac adaptation to aerobic exercise training includes improved cardiomyocyte contractility and calcium handling. Our objective was to determine whether cytosolic calcium/calmodulin-dependent kinase II and its downstream targets are modulated by exercise training. A six-week aerobic interval training program by treadmill running increased maximal oxygen uptake by 35% in adult mice, whereupon left ventricular cardiomyocyte function was studied and myocardial tissue samples were used for biochemical analysis. Cardiomyocytes from trained mice had enhanced contractility and faster relaxation rates, which coincided with larger amplitude and faster decay of the calcium transient, but not increased peak systolic calcium levels. These changes were associated with reduced phospholamban expression relative to sarcoplasmic reticulum calcium ATPase and constitutively increased phosphorylation of phospholamban at the threonine 17, but not at the serine 16 site. Calcium/calmodulin-dependent kinase IIdelta phosphorylation was increased at threonine 287, indicating activation. To investigate the physiological role of calcium/calmodulin-dependent kinase IIdelta phosphorylation, this kinase was blocked specifically by autocamtide-2 related inhibitory peptide II. This maneuver completely abolished training-induced improvements of cardiomyocyte contractility and calcium handling and blunted, but did not completely abolish the training-induced increase in Ca(2+) sensitivity. Also, inhibition of calcium/calmodulin-dependent kinase II reduced the greater frequency-dependent acceleration of relaxation that was observed after aerobic interval training. These observations indicate that calcium/calmodulin-dependent kinase IIdelta contributes significantly to the functional adaptation of the cardiomyocyte to regular exercise training.
Kemi
Ole J
OJ
Department of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway. o.kemi@bio.gla.ac.uk
Ellingsen
Oyvind
O
Ceci
Marcello
M
Grimaldi
Serena
S
Smith
Godfrey L
GL
Condorelli
Gianluigi
G
Wisløff
Ulrik
U
D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002135:Calcium-Binding Proteins / Q000737:chemistry / Q000378:metabolism*; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000378:metabolism*; D005260:Female; D008163:Luminescent Measurements; D051379:Mice; D008810:Mice, Inbred C57BL; D009200:Myocardial Contraction / Q000502:physiology*; D032383:Myocytes, Cardiac / Q000378:metabolism*; D010766:Phosphorylation; D010805:Physical Conditioning, Animal / Q000502:physiology*; D011897:Random Allocation; D013912:Threonine / Q000378:metabolism*; D000099211:Phospholamban
D002118:Calcium; D002135:Calcium-Binding Proteins; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D013912:Threonine; D000099211:Phospholamban; C517673:Camk2d protein, mouse
Med Sci Sports Exerc. 2000 Jan;32(1):89-93
10647534
J Mol Cell Cardiol. 2007 Jan;42(1):196-205
17052727
J Mol Cell Cardiol. 2000 Nov;32(11):2075-82
11040110
Cardiovasc Res. 2001 Jun;50(3):495-508
11376625
J Appl Physiol (1985). 2001 Jul;91(1):309-15
11408445
J Mol Cell Cardiol. 2001 Jun;33(6):1053-63
11444913
Cardiovasc Res. 2002 Apr;54(1):162-74
12062372
J Appl Physiol (1985). 2002 Oct;93(4):1301-9
12235029
J Mol Cell Cardiol. 2002 Aug;34(8):919-39
12234763
J Mol Cell Cardiol. 2002 Aug;34(8):975-84
12234767
Am J Physiol Heart Circ Physiol. 2003 Mar;284(3):H830-7
12424097
J Biol Chem. 2003 Jul 4;278(27):25063-71
12692124
Nat Rev Mol Cell Biol. 2003 Jul;4(7):566-77
12838339
Circulation. 2004 Jun 15;109(23):2897-904
15173028
Am J Physiol. 1990 Feb;258(2 Pt 2):H431-5
2137986
J Biol Chem. 1993 Aug 15;268(23):17018-25
8349590
J Mol Cell Cardiol. 1994 Jan;26(1):61-7
8196070
Am J Physiol. 1994 Aug;267(2 Pt 2):H812-20
8067437
Am J Physiol. 1995 Feb;268(2 Pt 2):H703-12
7864197
Circ Res. 1995 Apr;76(4):681-6
7534662
J Biol Chem. 1997 Jan 31;272(5):2852-60
9006928
Am J Physiol. 1998 Apr;274(4 Pt 2):H1335-47
9575939
Circ Res. 2004 Nov 26;95(11):e85-95
15528471
Science. 2005 Jan 21;307(5708):418-20
15662013
J Physiol. 2005 Feb 1;562(Pt 3):801-13
15528241
FASEB J. 2005 Apr;19(6):503-11
15791000
Cardiovasc Res. 2005 Jul 1;67(1):161-72
15949480
FASEB J. 2005 Jul;19(9):1137-9
15855227
J Biol Chem. 2000 Jul 21;275(29):22532-6
10825152